|
ORLANDO, FL, Feb 12, 2008 (MARKET WIRE via COMTEX) -- Cardiovascular Sciences,
Inc. (PINKSHEETS: CVSC) announced
that the Company is pleased to announce the appointment of John Martin of Virginia
Beach, VA to its board of directors. Mr. Martin has extensive corporate experience
including as the founder and president of Weight Loss Forever International,
Inc., a franchise operation with some two dozen locations in the southeast. As
the founder and president of that company, Mr. Martin helped formulate a line
of natural herb supplements that proved effective in the Weight Loss Forever
program. Mr. Martin also oversaw the corporate sites, addressed compliance of
the franchise sites and was responsible for all corporate governance. He nurtured
the company from its inception to a mature and very successful organization.
Dr. Larry Hooper, a physician and the CEO of Cardiovascular
Sciences, Inc., announced, "We
are so pleased to have John on board. His knowledge in the corporate world and
his leadership abilities promise to be an excellent and complementary fit with
the leadership of our company." He goes on to add, "John's
knowledge and skills will allow us to explore other, possibly
synergistic endeavors that will help speed our core technology
toward the market."
Cardiovascular Sciences, Inc., a member of the award winning
University of Central Florida Technology Incubator, has offices
in the Research Park adjacent to the UCF campus. The company
has developed, with Dr. Kevin Belfield, a technology that promises
to bring a much needed solution to the $6+ billion global market
dealing with post-surgical adhesions and their complications.
During many surgeries, stressed tissues can adhere to each other,
creating a scar that can cause complications from mild discomfort
to significant disability to life threatening obstruction. The
company's second generation material is currently going into
expanded animal trials and further development to widen the
range of applications in which it will be useful.
About Cardiovascular Sciences
Cardiovascular Sciences, Inc. is an advanced medical device
company which is developing a novel technology platform to address
the problem of post-surgical and post-traumatic adhesions. Adhesions
and the complications of adhesions are a significant problem
worldwide for a wide range of specialists, including general
surgeons, cardiothoracic surgeons, orthopedic, plastic, and
ophthalmologic and otolaryngology specialists to name just some
of them. In addition, the veterinary field has a tremendous
need for a product that can prevent similar problems in a wide
variety of animals.
The Company's unique materials and processes promise a more
cost-effective and decidedly more efficient and capable means
to deal with a problem that has been so devastating to so many.
Current sponsored research at the University of Central Florida
(UCF) and previously
at other institutions indicate that The Company is on the right
path and progressing well.
In addition to the anti-adhesion technology, The Company owns
technology in a variety of other areas, including thrombo-resistant
coatings, enhanced intra-arterial balloon pumping catheters,
cell engineered vascular tissues, and a method for improved
recovery of the heart following cardioplegia. This yields a
diversified portfolio with projects in various stages of development.
www.cvsciences.org
Forward-looking statements in this release are made pursuant
to the Safe Harbor Provisions of the Private Securities Litigation
Reform Act of 1995. These forward-looking statements are subject
to certain risks, and uncertainties and actual results could
differ from those discussed. This material is information only
and is not an offer or solicitation to buy or sell the securities.
For more information contact:
Cardiovascular Sciences Investor Relations
800-858-7502
ir@cvsciences.org
SOURCE: Cardiovascular Sciences
mailto:ir@cvsciences.org
Copyright 2008 Market Wire, All rights reserved.
http://www.foxbusiness.com/markets/industries/health-care/article/cardiovascular-sciences-announces-selection-new-member-board-directors_475484_10.html |
